Please email us at [email protected] with our item No, NDC#, UPC# or the product link if you have any quetions. We are located in Oceanside, California. Search over 110,000 items by Name, Item No., NDC, UPC (without dashes) or by Mfg.Name. Please note, Prescription items can only be ordered by a Drug Manufacturer, Wholesaler, Hospital, Governmental Medical Facility, VA, Pharmacy, Physician, Physician Assistant, Nurse Practitioner, Dentist, Podiatrist, Optometrist, Veterinarian, Naturopath, Licensed Lab, Physical Therapist & Pharmacist in their scope of practice. No order will ship, unless you you have provided us the Medical License (and DEA Lic. in case of controlled drug) and we had verified that. Rx items can only be shipped to AZ, AR, CA, CT, DE, FL, GA, GU, HI, IL, KS, KY, LA, ME, MA, MI, NJ, NY, PA, PR, TX, TN, VA, WA, WI and WV. If you are an International Physician or Pharmacist, please contact us before ordering.


Menu

Rx Item-Saxenda 3Mg liraglutide Sq 0.5Ml Inj 5X3Ml By Novo Nordisk Pharm

Item No.: RX388173 388173  NDC No.169280015 00169-2800-15 0169-2800-15 00169280015 0169-280015 UPC No.:301692800153 3-01692-80015-3 301692-800153  NDC No.00169-2800-15 UPC/GTIN No.3-01692-80015-3 MPN Item No.: RX388173 388173  NDC No.169280015 00169-2800-15 0169-2800-15 00169280015 0169-280015 UPC No.:301692800153 3-01692-80015-3 301692-800153  NDC No.00169-2800-15 UPC/GTIN No.3-01692-80015-3 MPN Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scopWant to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.comVisit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.

Rx Item-Saxenda 3Mg liraglutide Sq 0.5Ml Inj 5X3Ml By Novo Nordisk Pharm

$1618.82$1499.00

Item No.: RX388173 388173 NDC No.169280015 00169-2800-15 0169-2800-15 00169280015 0169-280015 UPC No.:301692800153 3-01692-80015-3 301692-800153 NDC No.00169-2800-15 UPC/GTIN No.3-01692-80015-3 MPN 00169-2800-15 Rx Item-Saxenda 3Mg liraglutide Sq 0.5Ml Inj 5X3Ml By Novo Nordisk Pharm Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,ResearchCo.,Uni.,VA,Vet & Wholesalers in scope of practice

Have a question?

Clinical Information
Gen. Code and Des.
73258 liraglutide SUBCUT PEN INJCTR 3 MG/0.5ML
GCN and Des.
37637 liraglutide SUBCUT PEN INJCTR 3 MG/0.5ML
Strength
18MG3ML
Dose Form
PEN INJECTOR (ML)
Product Category
RX Pharmaceuticals
Fine Line Class
850085008510 All Rx Products
DEA Class
NC
OMP Family

AHFS Class
68200600 INCRETIN MIMETICS
Active Ingredients
10773 liraglutide 204656202
Inactive Ingredients
2468 propylene glycol 57556
3199 phenol 108952



SAXENDA- liraglutide injection, solution
Novo Nordisk
WARNING: RISK OF THYROID C-CELL TUMORS


Liraglutide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures in both genders of rats and mice. It is unknown whether Saxenda causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans, as the human relevance of liraglutide-induced rodent thyroid C-cell tumors has not been determined [see Warnings and Precautions (5.1) and Nonclinical Toxicology (13.1)].

Saxenda is contraindicated in patients with a personal or family history of MTC and in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Counsel patients regarding the potential risk of MTC with use of Saxenda and inform them of symptoms of thyroid tumors (e.g., a mass in the neck, dysphagia, dyspnea, persistent hoarseness). Routine monitoring of serum calcitonin or using thyroid ultrasound is of uncertain value for early detection of MTC in patients treated with Saxenda [see Contraindications (4), Warnings and Precautions (5.1)].

1 INDICATIONS AND USAGE

Saxenda is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of


30 kg/m2 or greater (obese), or

27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)

Limitations of Use


Saxenda is not indicated for the treatment of type 2 diabetes mellitus.

Saxenda and Victoza� both contain the same active ingredient, liraglutide, and therefore should not be used together. Saxenda should not be used in combination with any other GLP-1 receptor agonist.

Saxenda has not been studied in patients taking insulin. Saxenda and insulin should not be used together [see Warnings and Precautions (5.4)].

The effects of Saxenda on cardiovascular morbidity and mortality have not been established.

The safety and effectiveness of Saxenda in combination with other products intended for weight loss, including prescription drugs, over-the-counter drugs, and herbal preparations, have not been established.

Saxenda has not been studied in patients with a history of pancreatitis [see Warnings and Precautions (5.2)].

2 DOSAGE AND ADMINISTRATION

The recommended dosage of Saxenda is 3 mg daily. The dose escalation schedule in Table 1 should be used to reduce the likelihood of gastrointestinal symptoms. If patients do not tolerate an increased dose during dose escalation, consider delaying dose escalation for approximately one additional week. Saxenda should be discontinued, however, if a patient cannot tolerate the 3 mg dose, as efficacy has not been established at lower doses (0.6, 1.2, 1.8, and 2.4 mg).
DOSAGE FORMS AND STRENGTHS

Solution for subcutaneous injection, pre-filled, multi-dose pen that delivers doses of 0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg, or 3 mg (6 mg/mL, 3 mL).

Item No.: RX388173 388173  NDC No.169280015 00169-2800-15 0169-2800-15 00169280015 0169-280015 UPC No.:301692800153 3-01692-80015-3 301692-800153  NDC No.00169-2800-15 UPC/GTIN No.3-01692-80015-3 MPN
RX ITEM-Saxenda 3Mg 0.5Ml Inj 5X3Ml By N
Item No.: RX388173 388173 NDC No.169280015 00169-2800-15 0169-2800-15 00169280015 0169-280015 UPC No.:301692800153 3-01692-80015-3 301692-800153 NDC No.00169-2800-15 UPC/GTIN No.3-01692-80015-3 MPN

Item No.: RX388173 388173  NDC No.169280015 00169-2800-15 0169-2800-15 00169280015 0169-280015 UPC No.:301692800153 3-01692-80015-3 301692-800153  NDC No.00169-2800-15 UPC/GTIN No.3-01692-80015-3 MPN
Saxenda 3Mg 0.5Ml Inj 5X3Ml By Novo Nord
Item No.: RX388173 388173 NDC No.169280015 00169-2800-15 0169-2800-15 00169280015 0169-280015 UPC No.:301692800153 3-01692-80015-3 301692-800153 NDC No.00169-2800-15 UPC/GTIN No.3-01692-80015-3 MPN

Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop
LIRAGLUTIDE SUB-Q PEN INJ
Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop

Want to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.com
Buy More Save More!
Want to do Research on this Med or need a large quantity? Email Details with quantity required to:[email protected]

Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.
AmericanPharmaWholesale.com
Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.